The Comprehensive Pain and Addiction Center initiative 2.3C will help lead Arizona and the nation to implement a socio-psycho-biological approach to pain management, substance misuse, and addiction.
2.3C Outcome Objectives:
- Funding: Receive 4 grants (2 state and 2 federal) totaling $2.64 million by June 2024. See 2.3C Projects below.
Education & Prevention: Setup 3 substance use education and training activities, one each for healthcare providers, UArizona Health Sciences students, and high school students using in-person, online, and telehealth approaches by June 2024.
- Education & Prevention: Establish a UArizona Health Sciences undergraduate program (Bachelors of Science in Medicine, 120 units) that includes substance use curriculum by December 2021.
- Education & Prevention: Support MAT Waiver trainings and the AzMAT Mentors Program and create an Office Based Opioid Treatment Implementation Program to support and establish practice procedures and policies by June 2024.
- Legislation: Create several documents that provide research summaries and policy recommendations for improving Arizona's capacity to address substance misuse by June 2024.
- Education & Prevention: Provide technical assistance to healthcare agencies, providers, and others working to improve capacity to successfully link post-overdose and at-risk patients to appropriate substance use services, follow-up care, and other resources.
2.3C Funded Projects:
Project FUTRE (Families Uplifted Through Recovery Education):
The University of Arizona Comprehensive Pain and Addiction Center, in collaboration with the Workforce Development Program, the Colleges of Public Health and Medicine, and the Arizona Center for Rural Health, received a four year, $2.74 million HRSA grant award. The collaboration launched Project FUTRE. The goal of Project FUTRE is to increase the number of behavioral health paraprofessionals who are trained to work with children and families impacted by opioid use disorder (OUD) and other substance use disorders (SUDs) in Pima and Santa Cruz counties. Click here for more details or to apply to Project FUTRE.
Arizona Rural Opioid Response-Implementation (AzRORI):
The University of Arizona Comprehensive Pain and Addiction Center received a one year, ~$70,000 subcontract from the Arizona Alliance for Community Health Centers, part of the RCORP-Implementation/HRSA grant award. The collaboration launched state-wide substance use training and technical assistance with a focus on Gila, Graham, and Mohave counties. The goal is to address barriers to accessing substance use disorder (SUD) treatment, including opioid use disorder (OUD). Click here for more details.
Foundation for Opioid Response Efforts (FORE):
The University of Arizona Southwest Institute for Research on Women (SIROW), in collaboration with the Comprehensive Pain and Addiction Center, received a 15-month, $230,357 FORE award. The collaboration launched Evidence for Action: COVID-19 as a Window of Opportunity to Normalize Medications for Opioid Use Disorder Access. The project will study the impact of COVID-19 on acccess to medication for opioid use disorder (MOUD) and patient health. The research team will document the impact of COVID-allowed policy changes through a survey of 1,000 Arizona MOUD providers and interview with 200 MOUD patients, with a focus on rural and tribal communities. Beth Meyerson at SIROW is the PI on the project, and Benjamin Brady, DrPH at CPAC is a Co-investigator. Click here for more details.
On December 8, 2020, Dr. Melody Glenn provided a CME event titled Treating Opioid Use Disorder (OUD) in Rural Communities. This training covered topics such as:
(a) a history of OUD treatment,
(b) addiction as a disease,
(c) harm reduction and stigma,
(d) overdose education and Naloxone distribution (OEND),
(e) medications for OUD (MOUD).
Dr. Melody Glenn presented part of this training series during the December 8, 2021. The videos expand on the training to provide a more in-depth look at addiction treatment history, harm reduction and overdose education and naloxone distribution, and medications to treat opioid use disorder.
Continuing Medical Education Opportunities:
Are you an Arizona physician authorized to prescribe Schedule II controlled substances that needs to complete their continuing medical education (CME) in opioid related, substance use disorder or addiction? This flyer lists various CME courses, free or payment required, state-wide and nation-wide that may help you obtain your required CME units for you licensing renewal period.